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1. Introduction
Breast cancer occurs when the cells in the lobules 
(milk producing glands) or the ducts become abnormal 
and divide uncontrollably. These abnormal cells begin to 
invade the surrounding breast tissue and may eventually 
spread via blood vessels and lymphatic channels to the 
lymph nodes, lungs, bones, brain and liver. As reported in 
the Breast Cancer Facts and Figure 2015-2016 by 
American Cancer Society, there are around 74% of breast 
cancer cases which estrogen receptors (ER) are over-
expressed and it is categorized as “ER-positive”. ER-
positive cancer cell growth is dependent towards 
estrogen. The growth is treated by the use of drug such as 
tamoxifen and raloxifene to block the estrogen receptor 
[2].  
Human estrogen receptor has two subtypes, alpha (ERα) 
and beta (ERβ). They have distinct tissue distributions, 
regulation different separate sets of gene and differ in 
their affinities and activity [4]. Ali & Combees [1] stated, 
“The presence of elevated levels of ERα in benign breast 
epithelium appears to indicate an increased risk of breast 
cancer, suggesting a role for ERα in breast cancer 
initiation, as well as progression.” In addition, 
overexpression of ERα is recurrently detected in the early 
stage of breast cancer as mentioned by Hayashi et al. [6]. 
They reported that the specific promoter of the ERα gene 
is important for enhanced transcription of the gene, and 
identified the cis-acting elements which play a crucial 
role in its transcription. Moreover, methylation of the 
ERα gene promoters also contributes to the regulation of 
gene transcription. Due to the critical role of estrogen in 
breast cancer development, it is necessary for the 
estrogen mechanism to be interrupted, for example by 
blocking of ERα. 
Zingiberofficinale, from the family Zingiberaceae, is 
commonly called ginger and is one of the most widely 
used species. It is a common additive in a large number of 
food products and beverages due to its flavor, color and 
pungency. Ginger is also reported to have medicinal 
properties that contains numerous bioactive compounds 
that have been shown to have antioxidant, anti-
inflammatory, antimicrobial, antiviral, antifungal, anti-
arthritic, hypotensive, antiatherogenic, radioprotective 
and antiemetic properties [2]. It can treat digestive 
disorders, nausea and vomiting, rheumatism, migraine 
and headaches and diabetes. The cancer preventive 
activities of ginger are supposed to be mainly due to free 
radical scavenging, antioxidant pathway, alteration of 
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gene expressions and induction of apoptosis, all of which 
contributes towardsdecrease in tumor initiation, 
promotion and progression [3]. Ginger also contains 
components shown to have anti-cancer effects, including 
various gingerols, gingerdione, shogaols, and paradols, as 
well as caffeic acid, β-elemene and zingerone. 
In this study, three common bioactive compounds found 
in ginger namely 6-paradol (6PRD), Zingerone (ZGR) 
and Zerumbone (ZRB) were examined for its application 
in the drug design against breast cancer using molecular 
docking tools to provide better analysis on their binding 
affinity against the human receptor alpha (ERα). 
 
2. Methodology 
2.1 Data collection 
The three-dimensional (3D) molecular structures of 
6PRD, ZGR and ZRB were downloaded from the 
PubChem database including the structure of 
hydroxytamoxifen (Figure 1). The compound identifier 
(CID) and other molecular information are listed in Table 
1. 3D structure of the ERα (ID: 2IOK) was downloaded 
from the Protein Data Bank (PDB) database and 
visualized in Figure 2.   
 
 
Fig. 1: Structural formula and the 3D structure of ligands 
molecule (carbon = green, oxygen = red, nitrogen = blue, 
polar hydrogen = grey). 
 
 
Table 1: Molecular information of the ligands structure 
 
Fig. 2: Three-dimensional structure of the dimeric human 
estrogen receptor alpha ligand-binding domain in 
complex with compound 1D (PDB ID: 2IOK) 
 
2.2 Molecular docking 
AutoDockTools (ADT) version 1.5.6, was used for 
molecular docking analysis [8]. ERα and ligands 
structures in PDB format were loaded into the docking 
system and extraneous water molecules were removed. 
To stabilize the protein system, hydrogen atoms and 
partial charges (Kollman and Gasteiger charges) were 
added to the protein. Then the molecules were exported 
and operated in PDBQT format. Binding region was 
specified within a grid map of 86 x 74 x 90 points with 
the default spacing of 0.375 Å. The grid box incorporates 
26 of the following ERα residues; Met343, Leu346, 
Thr347, Leu349, Ala350, Asp351, Glu353, Leu354, 
Trp383, Leu384, Leu387, Met388, Leu391, Arg394, 
Leu402, Phe404, Val418, Glu419, Gly420, Met421, 
Ile424, Phe425, Leu428, Gly521, His524 and Leu525. 
 
2.3 Molecular visualization of ERα 
complexes 
The resulting structures from docking were viewed and 
analyzed using PyMOL[9]. PyMOL was also used to 
display the measurement of the hydrogen bond distance 
between the interacting atoms. Schematic 2D 
representation of the molecular interaction between the 
ligand and the ERα active site was displayed and 
examined using LigPlot+ software [10]. Hydrophobic 
interaction and hydrogen bond formation with the ERα 
residues are presented in the 2D schematic. 
 
2.4 Ligand binding affinity analysis 
Results of molecular docking were obtained, analyzed 
and visualized using ADT, LigPlot+ and PyMOL. The 
parameters for determining the ligand binding affinity 
involves the assessment of the hydrogen bonding, 
hydrophobic interactions, binding energy and inhibition 
constant (Ki) of ligand-ERα complexes. 
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3. Results and discussions 
3.1Hydrogen bond and binding energy 
Hydrogen bond interaction was found to be crucial in the 
active site of ERα. The interaction may occur between 
hydrogen atom with electronegative atom such as 
nitrogen, oxygen or fluorine. Zhao and Huang [12] stated 
that hydrogen bonding is an exchange reaction whereby 
the hydrogen bonds and acceptors of the free protein and 
ligand break their hydrogen bonds with water and form 
new bonds in the protein-ligand complex.  
Predominant binding modes for the HTMX-ERα, 6PRD-
ERα, ZGR-ERα and ZRB-ERα ligand complexes were 
predicted using ADT version 1.5.6. The results were 
ranked according to the percentage of conformations 
formed in a cluster and by its correlating binding energy 
as presented in table 2.  
 
 
Table 2:  Docking simulation results based on the best 
rank of binding conformations and binding energy. 
 
Figure 3 represent the structure of HTMX-ERα that 
shows one hydrogen bonds are formed between 
hydroxytamoxifen and one active site residue which is 
Arg394. HTMX-ERα has the lowest binding energy (-
10.71 ± 0.43 kcal/mol). While 6PRD-ERα (Figure 4), two 
hydrogen bonds are formed from 6-paradol interaction 
with two active site residues, Glu353 and Arg394. 
However, the binding energy for 6PRD-ERα is higher (-
6.92 ± 0.14 kcal/mol) compared to HTMX-ERα. There 
are also two hydrogen bonds formation between ZGR-
ERα (Figure 5) and two active sites residues, Glu353 and 
Arg394 and the binding energy was highest of all four 
analyzed compound (-5.93 ± 0.31 kcal/mol). No 
hydrogen bond was formed from the docking of 
zerumbone and the binding energy was higher than 
HTMX-ERα but lower than 6PRD-ERα and ZGR-ERα.  
The lowest energy binding required to form ligand-
protein complex suggested better interaction in the active 
site [7]. In Table 2, it was observed that 
hydroxytamoxifen gave lowest binding energy followed 
by zerumbone, 6-paradol and zingerone respectively. 
However, this would be inconsistent with the second 
highest binding energy of zerumbone that has no 
hydrogen bond formation.  
 
 
 
 
 
Fig. 3:Molecular representation exhibits the formation of 
h-bond (yellow dash line) with atomic distance of 1.8 Å 
between hydroxytamoxifen and ARG394 in HTMX-ERα. 
The ribbon structure represents the ERα. 
 
 
Fig. 4: Molecular representation exhibits the formation of 
h-bond (yellow dash line) with atomic distance of 1.8 Å 
between 6-paradol and two residues, GLU353 and 
ARG394 in PRD-ERα. The ribbon structure represents 
the ERα. 
 
 
Fig. 5: Molecular representation exhibits the formation of 
h-bond (yellow dash line) with atomic distance of 1.8 Å 
between zingerone and two residues, GLU353 and 
ARG394 in ZGR-ERα. The ribbon structure represents 
the ERα. 
 
3.2 Binding energy range and inhibition 
constant  
As shown in Table 3, hydroxytamoxifen showed a 
binding energy of -10.71 ± 0.43 while 6-paradol, 
zingerone and zerumbone showed higher binding energy 
which are -6.92 ± 0.14, -5.93 ± 0.31 and -8.66 ± 0.04 
respectively. The relationship between the binding energy 
and conformation is displayed in Figure 6. It is shown 
that zingerone have highest binding energy level followed 
by 6-paradol, zerumbone and hydroxytamoxifen 
respectively. 
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Table 3: Binding energy of compounds based on docking 
ranks. 
Table 4: Inhibition constant of compounds based on 
docking ranks. 
 
Fig. 6: Binding energy of the compounds according to 
their docking ranks. 
 
Another parameter tested was the inhibition constant (Ki) 
of the compounds. As shown in Table 4, 
hydroxytamoxifen showed Ki value of 14.05 nM while 6-
paradol, zingerone and zerumbone showed Ki value of 
8.51 nM, 45.05 nM and 449.08 nM respectively. Ki value 
is reflective towards the compounds binding affinity. The 
smaller the Ki, the greater its binding affinity and the 
smaller the concentration needed to inhibit the activity of 
the ERα. In this study, paradol showed the lowest 
inhibition constant value compared to hydroxytamoxifen, 
zingerone and zerumbone. Based on the binding energy 
level and the related inhibition constant, it can be 
concluded that 6-paradol showed highest potential 
followed by hydroxytamoxifen, zingerone and zerumbone 
for the inhibition of ERα. Based on Table 2, there was no 
hydrogen bond formed between zerumbone and ERα 
because zerumbone has lowest Ki value which is 449.08 
nM compared to hydroxytamoxifen, 6-paradol and 
zingerone. 
 
3.3 Schematic 2D representation of H-bond 
and hydrophobic interaction 
Apart from hydrogen bond interaction, hydrophobic 
interaction also plays essential part in the active site. 
Although the interaction is not as strong as hydrogen 
bond, hydrophobic interaction can show remarkable 
changes in docking free energy between ligand and 
enzyme [11]. 
The resulting hydrophobic interaction analyzed from the 
docking structure is as presented in Figure 7, Figure 8, 
Figure 9 and Figure 10. The active site residues involved 
with the hydrophobic interaction in HTMX-ERα, 6PRD-
ERα, ZGR-ERα and ZRB-ERα were presented in Table 5. 
 
Table 5: Hydrophobic interacting residues of ERα 
 
Hydroxytamoxifen formed hydrophobic interaction with 
more residues compared to 6-paradol, zingerone and 
zerumbone. The hydrophobic contacts in HTMX-ERα 
have 17 interacting residues whereas 6-PRD-ERα, ZGR-
ERα and ZRB-ERα have 14, 12 and 12 interacting 
residues respectively. Three identical residues formed 
hydrophobic interaction in all complexes which are 
Glu353, Leu387 and Arg394. Although the number of 
molecules of 6-paradol, zingerone and zerumbone is 
comparatively lesser than hydroxytamoxifen, they 
showed relatively high number of hydrophobic contacts.  
Hydrogen bonding and hydrophobic interactions are 
important factors that affect the thermodynamics of 
ligand-receptor binding [5]. The stability of ligand-
receptor relationship is depends on hydrophobic contacts 
especially in the positioning of the ligands inside the 
binding site. The higher number of hydrophobic contacts 
in HTMX-ERα and the differing amino acid residues 
involved may have contributed to HTMX-ERα lowest 
binding energy and second lower in Ki value as compared 
to 6-PRD-ERα, ZGR-ERα and ZRB-ERα. Residues 
involved in hydrogen bonding in HTMX-ERα (Asp351 
and Arg394), 6-PRD-ERα (Glu353 and Arg394) and 
ZGR-ERα (Glu353 and Arg394) also form hydrophobic 
contacts with its respective ligand which further stabilizes 
the hydrogen bond formation.  
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Fig. 7:Schematic 2D representation of hydrophobic 
interaction and hydrogen bonding from docking analysis 
of HTMX-ERα (Interactions labeled in dash line, red = 
hydrophobic contacts, green = hydrogen bond). 
 
Fig. 8: Schematic 2D representation of hydrophobic 
interaction and hydrogen bonding from docking analysis 
of 6-PRD-ERα (Interactions labeled in dash line, red = 
hydrophobic contacts, green = hydrogen bond).  
 
 
Fig. 9: Schematic 2D representation of hydrophobic 
interaction and hydrogen bonding from docking analysis 
of ZGR-ERα (Interactions labeled in dash line, red = 
hydrophobic contacts, green = hydrogen bond).  
 
Fig. 10: Schematic 2D representation of hydrophobic 
interaction and hydrogen bonding from docking analysis 
of ZRB-ERα (Interactions labeled in dash line, red = 
hydrophobic contacts, green = hydrogen bond). No 
hydrogen bond was formed in ZRB-ERα. 
 
4. Conclusion 
The ligand binding affinity of 6-paradol, zingerone and 
zerumbone against estrogen receptor alpha (ERα) was 
evaluated using molecular docking analysis. The potential 
of the three bioactive compounds compared to the 
synthetic drug, hydroxytamoxifen was established. 
Results suggest that hydroxytamoxifen have high level of 
interactions with ERα active site in terms of hydrogen 
bonding and hydrophobic interactions. Three identical 
residues are involved in hydrophobic interaction in all 
four ligand-ERα complexes which are Glu353, Leu387 
and Arg394. All hydrogen bonded residues in HTMX- 
ERα, 6-PRD-ERα and ZGR-ERα also formed 
hydrophobic contacts with its respective ligands which 
specify the importance of the two interacting residues 
(Glu353 and Arg394). However, the binding energy of 
three ginger bioactive compounds is exceptionally higher 
than hydroxytamoxifen and thus poses low potential as 
substitute. Binding energy for zingerone is marginally 
lower than 6-paradol but with high variation in Ki value. 
While 6-paradol gave the lowest inhibition constant value 
compared to hydroxytamoxifen, zingerone and 
zerumbone. Estradiol is a form of estrogen that is 
commonly used in hormone replacement therapy (HRT) 
along with the administration of hydroxytamoxifen as 
treatment against ER-positive breast cancer. The use of 
estradiol remains controversial due to the high risk of 
adverse effect. According to the findings of this study, 
zingerone show potential for further studies to determine 
a substitute for the estradiol in HRT against ER-positive 
breast cancer. Wide range of other bioactive compounds 
of ginger are also excluded in this research and thus can 
be used as an extension to this study.  
 
Acknowledgement 
The author wish to acknowledge International Islamic 
University Malaysia for funded this study under RIGS 
15-120-0120 grant.  
 
 117 
Faez S., et al., Int. J. Of Integrated Engineering:Special Issue 2018: Data Information Engineering: Vol. 10 No. 6 (2018) p. 113-118 
 
References 
[1] Ali, S., &Coombes, R. C. (2000). Estrogen receptor 
alpha in human breast cancer: occurrence and 
significance. J Mammary Gland Biol Neoplasia, 
5(3), 271–281. 
[2] Ali, B. H., Blunden, G., Tanira, M. O., &Nemmar, 
A. (2008). Some phytochemical, pharmacological 
and toxicological properties of ginger ( 
Zingiberofficinale Roscoe ): A review of recent 
research. Food ChemToxicol,46, 409–420. 
[3] Baliga, S, Baliga, V. and Kandathil S. (2011). A 
review of the chemistry and pharmacology of the 
date fruits (Phoenix dactylifera L.). Food Research 
International, 44: 1812-22. 
[4] Katzenellenbogen, B. S., Katzenellenbogen, J. A., 
& Medicine, C. (2000). Estrogen receptor 
transcription and transactivation Estrogen receptor 
alpha and estrogen receptor beta : regulation by 
selective estrogen receptor modulators and 
importance in breast cancer. Breast Cancer Res, 
2(5): 335–344. 
[5] Krotzky T. and Klebe G. (2015). Acceleration of 
Binding Site Comparisons by Graph Partitioning. 
Mol Inform, 34(8):550-8 
[6] Hayashi, S. I., Eguchi, H., Tanimoto, K., Yoshida, 
T., Omoto, Y., Inoue, Yamaguchi, Y. (2003). The 
expression and function of estrogen receptor alpha 
and beta in human breast cancer and its clinical 
application. Endocrine-Related Cancer, 10(2), 
193–202. 
[7] Priya R. and Vasugi R. (2015). Treatment of 
colorectal cancer using nanotechnology. 
International Journal Of Pharmacy & Technology, 
7(2), 8977-8985. 
[8] Sanner, M.F. (1999). Python: a programming 
language for software integration and development. 
J. Mol. Graph Model, 17, 57–61. 
[9] Seeliger D. and de Groot B. L. (2010). Ligand 
docking and binding site analysis with PyMOL and 
Autodock/Vina. J Comput Aided Mol Des, 
24(5):417-22. 
[10] Wallace, A., C., Laskowski, R., A., & Thornton, J., 
M., (1995). LIGPLOT: A program to generate 
schematic diagrams of protein-ligand interactions. 
Protein Engineering, 8(2), 127-134. 
[11] Wei D. Q., Zhang R., Du Q. S., Gao W.N., Li Y., 
Gao H., Wang S. Q., Zhang X., Li A. X., Sirois S. 
and Chou K.C. (2006). Anti-SARS drug screening 
by molecular docking. Amino Acids, 31(1):73-80. 
[12] Zhao, H. & Huang, D. (2011). Hydrogen Bonding 
Penalty upon Ligand Binding. PLoS ONE, 6(6), 
e19923. 
 
 118 
